non-nucleoside NS5b polymerase inhibitors (Biota)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namenon-nucleoside NS5b polymerase inhibitors (Biota)
Drug Alias NameBTA-6BTA-C445BTA-7BTA-C615BTA-5
ClassificationSmall molecules
Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors
TargetsHepatitis C virus NS5B RNA-dependent RNA polymerase
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiota Holdings Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVaxart Inc
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A